ストックスクリーナーアプリを入手
55.64
4.87%
-2.85
アフターアワーズ：
56.00
0.36
+0.65%
前日終値:
$58.49
開ける：
$59.02
24時間の取引高:
2.17M
Relative Volume:
1.55
時価総額：
$8.03B
収益：
-
当期純損益:
$-766.63M
株価収益率:
-9.7527
EPS:
-5.7051
ネットキャッシュフロー:
$-712.55M
1週間 パフォーマンス:
-5.26%
1か月 パフォーマンス:
-4.69%
6か月 パフォーマンス:
+38.00%
1年 パフォーマンス:
+62.31%
1日の値動き範囲:
$54.12
$59.66
1週間の範囲:
$54.12
$59.66
52週間の値動き範囲:
$28.09
$65.00
Vaxcyte Inc Stock (PCVX) Company Profile
名前
Vaxcyte Inc
セクター
電話
650-837-0111
住所
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
Compare PCVX vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PCVX
Vaxcyte Inc
|
55.64 | 8.45B | 0 | -766.63M | -712.55M | -5.7051 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 109.34B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 74.35B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 50.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 39.78B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.02B | 5.36B | 287.73M | 924.18M | 2.5229 |
Vaxcyte Inc Stock (PCVX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-07 | 繰り返されました | Needham | Buy |
| 2025-09-12 | 開始されました | Goldman | Neutral |
| 2025-04-22 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-12-20 | 開始されました | Goldman | Buy |
| 2023-12-07 | 開始されました | Mizuho | Buy |
| 2023-04-18 | 開始されました | TD Cowen | Outperform |
| 2023-01-03 | 繰り返されました | Needham | Buy |
| 2022-12-15 | 開始されました | Guggenheim | Buy |
| 2022-11-17 | 開始されました | BTIG Research | Buy |
| 2021-12-29 | 再開されました | Jefferies | Buy |
| 2021-06-24 | 再開されました | Jefferies | Buy |
| 2020-07-07 | 開始されました | BofA Securities | Buy |
| 2020-07-07 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-07-07 | 開始されました | Needham | Buy |
すべてを表示
Vaxcyte Inc (PCVX) 最新ニュース
How (PCVX) Movements Inform Risk Allocation Models - Stock Traders Daily
Jennison Associates LLC Has $31.26 Million Stock Position in Vaxcyte, Inc. $PCVX - MarketBeat
Vaxcyte's Manufacturing-Backed Vaccine Platform Is Redefining The PCV Market - Seeking Alpha
Vaxcyte COO Jim Wassil sells $127,869 in PCVX shares By Investing.com - Investing.com Canada
Insider Sell Alert: Jim Wassil Sells Shares of Vaxcyte Inc (PCVX) - GuruFocus
Vaxcyte (NASDAQ:PCVX) COO Sells $127,867.50 in Stock - MarketBeat
Vaxcyte COO Jim Wassil sells $127,869 in PCVX shares - Investing.com
Vaxcyte (PCVX) COO Jim Wassil sells 2,250 shares in Rule 10b5-1 trade - Stock Titan
PCVX (PCVX) insider James Wassil files planned sales totaling $566,913.91 - Stock Titan
Vaxcyte Executive Compensation, Directors, and Corporate Governance Overview 2025 - Minichart
Universal Beteiligungs und Servicegesellschaft mbH Raises Stake in Vaxcyte, Inc. $PCVX - MarketBeat
Vanguard (PCVX) holds 7.25M Vaxcyte shares, reports 5.03% stake - Stock Titan
Pictet Asset Management Holding SA Has $40.67 Million Stock Position in Vaxcyte, Inc. $PCVX - MarketBeat
Vaxcyte (PCVX) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring the 83% Potential Upside in Vaccine Innovation - DirectorsTalk Interviews
Vaxcyte, Inc. (NASDAQ:PCVX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Vaxcyte launches proposed $500M public offering of stock, warrants - MSN
Vaxcyte Completes Enrollment for Phase 3 VAX-31 Vaccine Trials - HarianBasis.co
[ARS] Vaxcyte, Inc. SEC Filing - Stock Titan
Vaxcyte (NASDAQ: PCVX) 2026 proxy on directors, auditor and say-on-pay - Stock Titan
Vaxcyte Inc (PCVX)’s VAX-31 Enters Critical Trial Stage - Insider Monkey
5 Best 52-Week High US Stocks to Buy - Insider Monkey
Trading Systems Reacting to (PCVX) Volatility - Stock Traders Daily
InvestingPro Fair Value predicted Vaxcyte’s 36% decline By Investing.com - Investing.com South Africa
Vaxcyte, Inc. (PCVX) Investor Outlook: A Deep Dive Into Its 74.82% Upside Potential - DirectorsTalk Interviews
Vaxcyte (NASDAQ:PCVX) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Insiders At Vaxcyte Sold US$1.0m In Stock, Alluding To Potential Weakness - 富途牛牛
Needham Maintains Vaxcyte(PCVX.US) With Buy Rating, Maintains Target Price $110 - Moomoo
Vaxcyte (PCVX) Stock Insider Selling (Edges Lower) 2026-04-15Large Cap Trends - Cổng thông tin điện tử tỉnh Tây Ninh
PCVX: Pivotal VAX-31 data and BLA filing expected within 15 months, backed by strong cash reserves - TradingView
PCVX Q4 2025 Earnings: Vaxcyte Inc. Misses EPS Estimates, Reports No RevenueExpert Market Insights - UBND thành phố Hải Phòng
PCVX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Vaxcyte (NASDAQ:PCVX) Stock Rating Lowered by Wall Street Zen - MarketBeat
How Vaxcyte Inc. (PCVX) Affects Rotational Strategy Timing - Stock Traders Daily
Is It Too Late To Consider Vaxcyte (PCVX) After A 95% One-Year Share Price Jump? - Yahoo Finance
What is the target price for Vaxcyte Inc stock2026 Momentum Check & AI Forecasted Entry/Exit Points - baoquankhu1.vn
PCVX SEC FilingsVaxcyte, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Vaxcyte CAO Sells $180,000 in Company Stock - National Today
Vaxcyte CAO Sells $180,000 in Stock - National Today
Insider Selling: Vaxcyte (NASDAQ:PCVX) CAO Sells 3,000 Shares of Stock - MarketBeat
Vaxcyte (PCVX) finance chief sells 3,000 shares after option exercise - Stock Titan
Vaxcyte to Present at Annual Healthcare Conference - National Today
Vaxcyte Inc stock: Why its pneumococcal vaccine pipeline draws investor focus - AD HOC NEWS
Vaxcyte to Present at the 25th Annual Needham Virtual Healthcare Conference - Sahm
Elvia Cowan registers 3,000-share sale (PCVX) after option exercise - Stock Titan
Vaxcyte (PCVX) Stock Analysis Report | Financials & Insights - Benzinga Japan
Vaxcyte, Inc. (PCVX) Investor Outlook: An 86.71% Potential Upside Raises Eyebrows - DirectorsTalk Interviews
Aberdeen Group plc Increases Holdings in Vaxcyte, Inc. $PCVX - MarketBeat
Vaxcyte Inc (PCVX) 財務データ
収益
当期純利益
現金流量
EPS
0.14%
0.48%
大文字化:
|
ボリューム (24 時間):